Key findings showed that HPV E6 and E7 oncoproteins interfere with tumor suppressor pathways (e.g., p53 and Rb), and activate PI3K/Akt, Wnt/β-catenin, and NF-κB signaling. This evidence concerns the gene TP53 and neoplasm.